학술논문
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Document Type
Article
Author
Cascone, T.; William, W.N.; Chen, L.; Pradhan, M.; Guo, H.; Negrao, M.V.; Le, X.; Gay, C.M.; Tsao, A.S.; Byers, L.A.; Altan, M.; Glisson, B.S.; Fossella, F.V.; Elamin, Y.Y.; Blumenschein, G.; Zhang, J.; Skoulidis, F.; Wu, J.; Wistuba, I.I.; Gibbons, D.L.; Heymach, J.V.; Leung, C.H.; Lin, H.Y.; Jack Lee, J.; Weissferdt, A.; Pataer, A.; Feldman, H.; Zhou, N.; Mehran, R.J.; Rice, D.C.; Walsh, G.L.; Hofstetter, W.L.; Rajaram, R.; Antonoff, M.B.; Swisher, S.G.; Vaporciyan, A.A.; Sepesi, B.; Carter, B.W.; Godoy, M.C.B.; Xi, Y.; Wang, J.; Basu, S.; Sun, J.J.; Yadav, S.S.; Allison, J.P.; Sharma, P.; Rojas Alvarez, F.R.; Lee, Y.; Sinjab, A.; Fujimoto, J.; Solis, L.M.; Parra, E.R.; Haymaker, C.; Kadara, H.; Mishra, A.K.; Ajami, N.J.; Wargo, J.A.
Source
In: Nature Medicine . (Nature Medicine, March 2023, 29(3):593-604)
Subject
Language
English
ISSN
1546170X
10788956
10788956